Recombinant Rat Protein Mis18-alpha (Mis18a)

What is Mis18-alpha and what is its primary function in cellular processes?

Mis18-alpha (Mis18a) is a critical component of the Mis18 complex required for recruitment of CENP-A to centromeres and normal chromosome segregation during mitosis . It forms a functional complex with Mis18-beta (Mis18β) and Mis18-binding protein 1 (Mis18BP1) that acts as a licensing factor for new CENP-A deposition . The protein contains a well-conserved globular domain called the Yippee domain (also known as the MeDiY domain) that mediates crucial protein-protein interactions . The human Mis18A protein is approximately 233 amino acids in length .

How is the Mis18 complex structurally organized and what domains mediate its assembly?

The Mis18 complex exhibits a sophisticated structural organization:

• The core structure includes a Mis18α Yippee homodimer as the central scaffold

• Two copies of Mis18α/β Yippee heterodimers associate with this core

• Two heterotrimers made of Mis18α/β C-terminal helices (typically 2 Mis18α and 1 Mis18β molecules) complete the assembly

• The C-terminal helical bundle assembly of Mis18α is essential for centromere localization

This hetero-hexameric structure creates binding interfaces for Mis18BP1, forming the complete hetero-octameric Mis18 core complex that is functional at centromeres .

What experimental evidence confirms the interaction between Mis18-alpha and other centromeric proteins?

Multiple experimental approaches have demonstrated Mis18-alpha interactions:

• Co-immunoprecipitation (Co-IP) assays using anti-Mis18α antibodies confirm complex formation with Mis18β-GFP in cell-based systems

• Size exclusion chromatography (SEC) analysis reveals that mutations in specific interfaces (e.g., C154 and D160) disrupt oligomerization patterns

• Cross-linking mass spectrometry (CLMS) identifies specific contacts between Mis18α and its binding partners

• STRING database analysis shows high confidence scores (0.999) for Mis18A interactions with both OIP5 (Mis18β) and MIS18BP1

What expression systems yield optimal results for recombinant Mis18-alpha production?

For successful recombinant Mis18-alpha expression:

• Escherichia coli BL21 (DE3) using auto-inducible expression systems has proven effective

• Expression of full-length protein or specific domains (Yippee domain, C-terminal domains) can be optimized separately depending on research needs

• Co-expression with binding partners like Mis18β may improve solubility and folding for certain applications

• Protein tags such as His-MBP can significantly enhance solubility and facilitate purification

What is the recommended purification protocol for obtaining highly pure Mis18-alpha protein?

The following multi-step purification approach yields high-quality Mis18-alpha:

• Cell lysis using ultra-sonication in buffer containing 30 mM Tris-HCl pH 7.5, 500 mM NaCl, and 5 mM β-mercaptoethanol with protease inhibitors

• Clarification by centrifugation at 20,000 × g for 50 min at 4°C followed by 0.45 μm filtration

• Initial affinity purification using cobalt affinity column with elution in 300 mM imidazole

• Secondary purification via amylose affinity column

• On-column cleavage of affinity tags using TEV protease (1:100 ratio) overnight at a4°C

This protocol can be adapted based on specific construct designs and experimental requirements.

What challenges might researchers encounter when working with recombinant Mis18-alpha and how can they be addressed?

Common challenges include:

• Protein aggregation due to exposed hydrophobic regions in the C-terminal helical domains

• Improper folding of the Yippee domain affecting functional activity

• Loss of oligomerization capacity after tag removal

• Reduced stability during storage and freeze-thaw cycles

Solutions include optimizing buffer composition (consider adding glycerol or specific salt concentrations), expressing the protein with stabilizing fusion partners, and carefully controlling temperature during purification steps.

How can researchers confirm that purified recombinant Mis18-alpha is functionally active?

Functional validation strategies include:

• Binding assays with known partners (Mis18β, Mis18BP1) using pull-down experiments

• Size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) to verify proper oligomerization state

• Circular dichroism to confirm secondary structure integrity

• Cell-based rescue experiments in Mis18α-depleted backgrounds to assess functional complementation

• Assessment of the protein's ability to support CENP-A loading in reconstitution systems

What cell-based assays can effectively measure Mis18-alpha activity?

Cellular assays to measure Mis18-alpha function include:

• Immunofluorescence microscopy to analyze centromeric localization of fluorescently tagged Mis18α constructs (wild-type vs mutants)

• CENP-A-SNAP pulse-chase labeling to quantify new CENP-A deposition at centromeres

• Tethering experiments using TetR-eYFP-Mis18α systems to assess recruitment capacity to non-centromeric sites

• Chromosome segregation analysis following expression of wild-type or mutant Mis18α in depleted backgrounds

• Co-localization studies with centromeric markers to measure recruitment efficiency

How do mutations in specific domains of Mis18-alpha affect its function?

Different mutations have distinct functional consequences:

These mutations demonstrate how specific structural elements contribute to different aspects of Mis18-alpha function.

How does Mis18-alpha contribute to centromere assembly independently of Mis18-beta?

Experimental evidence suggests Mis18α can partially function independently of Mis18β:

What is the role of cell cycle regulation in controlling Mis18-alpha function?

Mis18-alpha function is tightly regulated throughout the cell cycle:

• The Mis18 complex assembly is controlled by CDK1-mediated phosphorylation

• Phosphorylation sites on Mis18BP1 (T40 and S110) directly disrupt Mis18 complex assembly

• These phosphorylation sites lie within the Mis18α/β binding interface

• This regulatory mechanism restricts Mis18 complex formation and CENP-A loading to specific cell cycle phases

• Proper timing of Mis18α activity is essential for maintaining centromere identity during cell division

How can researchers design experiments to study the dynamics of Mis18-alpha at centromeres?

Advanced experimental approaches include:

• Live cell imaging with fluorescently tagged Mis18α to track recruitment dynamics throughout the cell cycle

• Fluorescence recovery after photobleaching (FRAP) to measure protein turnover rates at centromeres

• Single-molecule tracking to analyze residence times and movement patterns

• Proximity labeling (BioID, APEX) to identify transient interaction partners at different cell cycle stages

• Correlative light and electron microscopy to analyze the ultrastructural context of Mis18α localization

What controls should be included when studying Mis18-alpha localization and function?

Essential controls for Mis18-alpha research include:

• Wild-type Mis18α constructs alongside mutant variants to establish baseline localization and interaction profiles

• Mis18α-depleted negative controls to confirm antibody specificity and assess rescue efficiency

• Empty vector controls in transfection experiments to account for non-specific effects

• Untransfected cells when using fluorescently tagged constructs to establish background levels

• Positive controls for centromere localization using established markers (CENP-A, CENP-C)

• Beads-only or irrelevant protein controls in pull-down and Co-IP experiments

How should researchers interpret discrepancies between in vitro binding data and cellular localization results?

When facing conflicting data:

• Consider that in vitro systems lack cellular components that may stabilize or regulate interactions

• Examine whether post-translational modifications present in cells but absent in recombinant systems affect binding

• Evaluate whether cellular compartmentalization influences protein availability and local concentrations

• Test additional mutations or truncations to identify regulatory regions that might explain discrepancies

• Employ orthogonal techniques that bridge the gap between in vitro and cellular contexts (e.g., crosslinking approaches)

What factors should be considered when comparing rat Mis18-alpha to human or other mammalian orthologs?

Key comparative factors include:

• Sequence conservation in functional domains (particularly the Yippee domain and C-terminal helical regions)

• Species-specific post-translational modification sites that might affect regulation

• Differences in binding affinities with partners like Mis18β and Mis18BP1

• Potential variations in oligomerization properties

• Species-specific cell cycle regulatory mechanisms that might influence timing of activity

How can researchers quantitatively analyze Mis18-alpha centromeric localization data?

Robust quantitative analysis includes:

• Measuring fluorescence intensity of Mis18α-tagged constructs at centromeres using standardized imaging parameters

• Normalizing centromeric signal to background or total cellular levels

• Comparing wild-type and mutant localization using appropriate statistical tests

• Analyzing co-localization with centromeric markers through Pearson's correlation coefficient

• Quantifying the percentage of cells showing centromeric localization in different experimental conditions

• Tracking changes in localization patterns throughout the cell cycle

What approaches can resolve oligomeric states of Mis18-alpha in solution?

Multiple complementary techniques can characterize oligomeric states:

• Size exclusion chromatography (SEC) to separate different oligomeric forms based on size

• Multi-angle light scattering (MALS) coupled with SEC for absolute molecular weight determination

• Analytical ultracentrifugation to characterize sedimentation properties and heterogeneity

• Native mass spectrometry to identify specific oligomeric species

• Chemical crosslinking followed by SDS-PAGE to capture transient oligomeric states

How should dose-response relationships be established when studying Mis18-alpha function?

To establish meaningful dose-response relationships:

• Test multiple concentration points spanning at least 2-3 orders of magnitude

• Include both sub-effective and saturating concentrations

• Calculate EC50 or IC50 values using appropriate curve-fitting methods

• Compare dose-response curves between wild-type and mutant variants

• Ensure measurements are taken at steady-state conditions for each concentration

• Consider the potential for cooperative effects in oligomeric assemblies

What strategies can overcome poor centromeric localization of recombinant Mis18-alpha constructs?

When facing localization problems:

• Verify construct design to ensure all required domains are present and correctly folded

• Test different tag positions (N-terminal vs. C-terminal) as they may interfere with localization

• Evaluate expression levels, as overexpression might saturate binding sites or disrupt stoichiometry

• Consider co-expressing interaction partners like Mis18β to facilitate proper localization

• Test cell synchronization approaches, as Mis18α localization is cell cycle-dependent

• Ensure endogenous Mis18α is effectively depleted if using replacement strategies

How can researchers address protein stability issues with purified Mis18-alpha?

To improve protein stability:

• Optimize buffer composition (consider testing different pH values, salt concentrations, and additives)

• Include stabilizing agents such as glycerol (5-10%) or low concentrations of reducing agents

• Avoid repeated freeze-thaw cycles by preparing single-use aliquots

• Consider co-purification with binding partners that might stabilize the native conformation

• Test limited proteolysis approaches to identify and remove unstable regions while maintaining core functions

What approaches can resolve protein aggregation problems during Mis18-alpha expression?

To minimize aggregation:

• Lower expression temperature (16-18°C) to slow folding and reduce inclusion body formation

• Express as fusion proteins with solubility-enhancing tags (MBP, SUMO, TRX)

• Co-express with chaperones to assist proper folding

• Use lysis buffers with mild detergents or higher salt concentrations to prevent aggregation

• Consider on-column refolding strategies if inclusion bodies cannot be avoided

What emerging technologies could enhance our understanding of Mis18-alpha function?

Promising new approaches include:

• Cryo-electron microscopy to resolve the complete structure of the Mis18 complex

• Optogenetic tools to control Mis18α recruitment with spatial and temporal precision

• Single-cell proteomics to analyze variability in Mis18α interactions across different cells

• CRISPR-based screening to identify new regulators of Mis18α function

• Integrative structural biology combining X-ray crystallography, NMR, and crosslinking mass spectrometry

How might studies of Mis18-alpha contribute to understanding centromere-related diseases?

Mis18-alpha research has implications for:

• Chromosomal instability syndromes characterized by segregation errors

• Cancer progression mechanisms involving centromere dysfunction

• Age-related aneuploidy and its contribution to cellular aging

• Developmental disorders associated with cell division defects

• Potential therapeutic approaches targeting centromere assembly mechanisms

What are the key unanswered questions regarding Mis18-alpha mechanism of action?

Critical knowledge gaps include:

• The precise molecular mechanism by which Mis18α facilitates CENP-A deposition

• How Mis18α recognizes centromeric chromatin in a sequence-independent manner

• The complete network of Mis18α interactors beyond the core Mis18 complex

• Species-specific differences in Mis18α regulation and function

• The potential roles of Mis18α in processes beyond centromere maintenance